Sanaria Wins Best Logistics Technology and Cold Chain Delivery Award

On April 2nd, 2024, Sanaria Inc. won the Best Logistics Technology and Cold Chain Delivery Award at the Vaccine Industry Excellence (ViE) Awards at the World Vaccine Congress in Washington, D.C. A big shout out to Sanaria’s Vaccine Stabilization and Logistics team, lead by Dr. Eric James!

Sanaria received the award based on the following:

PfSPZ vaccines are live eukaryotic cell vaccines that are transported all over the world at temperatures below -150 °C using a robust liquid nitrogen vapor phase (LNVP) cold chain that can run independently of electricity, which can be unreliable or absent, or other energy sources (propane, kerosene). The cold chain allows mass storage to last mile delivery using LNVP cryoshippers which can hold vaccine for up to 28 days, ideal for the remote regions where malaria health facilities are often not available.

To ensure that PfSPZ vaccines can be used anywhere rather than in specialist facilities, Sanaria has developed a unique plastic cryovial with a septum that maintains closure integrity at ultra-low temperatures. These two innovations mean that vaccine can be delivered to any remote location for administration rather than recipients needing to travel to clinics for immunizations.

The PfSPZ vaccines cold chain covers all steps from fill-finish, through high stability storage, global distribution and last mile, ending at vaccine thawing and administration by syringe, and a cost-efficient, hub-and-spoke distribution system adaptable for use in all situations has been modeled suggesting that PfSPZ vaccines will be accessible, affordable and implementable. To date, PfSPZ vaccines have been successfully delivered, stored locally, and administered to volunteers in 38 clinical trials, including in 7 African countries and Indonesia, often in remote settings.